Effect of pentobarbitone on hypoxic ventilatory drive in man: Preliminary study

Area of Science:

• Pharmacology
• Respiratory Physiology
• Exercise Physiology

Background:

• The hypoxic ventilatory drive is a critical physiological response to low oxygen levels.
• Understanding factors influencing this drive is crucial for assessing respiratory health and drug effects.

Purpose of the Study:

• To investigate the impact of a specific dose of pentobarbitone on the hypoxic ventilatory drive in human volunteers.
• To identify potential individual variability in response to pentobarbitone concerning respiratory control.

Main Methods:

• Ten healthy volunteers received an intramuscular injection of pentobarbitone (2 mg/kg).
• Ventilatory responses to hypoxia were measured before and at intervals after drug administration.
• Physical fitness was assessed using resting heart rate and maximal oxygen uptake.

Main Results:

• Five subjects exhibited a significant depression in their ventilatory response to hypoxia 30 minutes post-injection.
• This depression in respiratory response persisted for up to 90 minutes in affected individuals.
• The remaining five subjects showed no significant alteration in their hypoxic ventilatory drive.
• Differences in resting heart rate and maximal oxygen uptake suggested a correlation between physical fitness and drug response.

Conclusions:

• Intramuscular pentobarbitone can variably depress the hypoxic ventilatory drive in humans.
• Individual differences in physical fitness may influence the susceptibility to pentobarbitone-induced respiratory depression.
• Further research is warranted to elucidate the mechanisms underlying this variability.